References:
1. Subasty J. A Study to Assess the Effectiveness of Information Booklet on Prevention of COVID19 among Adolescents at Selected Village, Coimbatore: PPG College of Nursing, Coimbatore; 2021.
2. Hopkins C, Kumar N. Loss of sense of smell as marker of COVID-19 infection. The Royal College of Surgeons of England: British Rhinological Society. 2020:1-2.
3. Kanjanaumporn J, Aeumjaturapat S, Snidvongs K, Seresirikachorn K, Chusakul S. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options. Asian Pacific Journal of Allergy and Immunology. 2020;38(2):69-77.
4. van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, et al. COVID‐19: immunopathology, pathophysiological mechanisms, and treatment options. The Journal of pathology. 2021;254(4):307-31.
5. Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schöpf V, Mainland JD, et al. Anosmia—a clinical review. Chemical senses. 2017;42(7):513-23.
6. Lee DY, Lee WH, Wee JH, Kim J-W. Prognosis of postviral olfactory loss: follow-up study for longer than one year. American journal of rhinology & allergy. 2014;28(5):419-22.
7. Klimek L, Hagemann J, Döge J, Freudelsperger L, Cuevas M, Klimek F, et al. Olfactory and gustatory disorders in COVID-19. Allergo journal international. 2022;31(7):243-50.
8. Li J, Liu H-H, Yin X-D, Li C-C, Wang J. COVID-19 illness and autoimmune diseases: recent insights. Inflammation Research. 2021;70:407-28.
9. Di Stadio A, D’Ascanio L, Vaira LA, Cantone E, De Luca P, Cingolani C, et al. Ultramicronized palmitoylethanolamide and luteolin supplement combined with olfactory training to treat post-COVID-19 olfactory impairment: a multi-center double-blinded randomized placebo-controlled clinical trial. Current neuropharmacology. 2022;20(10):2001-12.
10. Saussez S, Vaira LA, Chiesa-Estomba CM, Le Bon SD, Horoi M, Deiana G, et al. Short-term efficacy and safety of oral and nasal corticosteroids in COVID-19 patients with olfactory dysfunction: a European multicenter study. Pathogens. 2021;10(06):698.
11. Duncan RB, Briggs M. Treatment of uncomplicated anosmia by vitamin A. Archives of otolaryngology. 1962;75(2):116-24.
12. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. European Archives of Oto-rhino-laryngology. 2017;274:2819-25.
13. Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. The American journal of the medical sciences. 2009;337(6):396-406.
14. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Archives of Otolaryngology–Head & Neck Surgery. 2012;138(11):1064-70.
15. Addison AB, Wong B, Ahmed T, Macchi A, Konstantinidis I, Huart C, et al. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction. Journal of Allergy and Clinical Immunology. 2021;147(5):1704-19.
16. El-Anwar MW, Elzayat S, Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx. 2020;47(4):559-64.
17. Luers J, Rokohl A, Loreck N, Wawer Matos P, Augustin M, Dewald F. Olfactory and gustatory dysfunction in coronavirus disease 19 (COVID-19) Clin Infect Dis. 2020;(May) doi: 10.1093/cid/ciaa525. Published online[Europe PMC free article][Abstract][CrossRef][Google Scholar].
18. Lv H, Zhang W, Zhu Z, Xiong Q, Xiang R, Wang Y, et al. Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID‑19 in Wuhan, China. International Journal of Infectious Diseases. 2020;100:507-12.
19. Le Bon S-D, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell. European Archives of Oto-rhino-laryngology. 2021;278:3113-7.
20. Abdelalim AA, Mohamady AA, Elsayed RA, Elawady MA, Ghallab AF. Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: a randomized controlled trial. American journal of otolaryngology. 2021;42(2):102884.
21. Hintschich CA, Dietz M, Haehner A, Hummel T. Topical administration of mometasone is not helpful in post-COVID-19 olfactory dysfunction. Life. 2022;12(10):1483.
22. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is beneficial in post-infectious olfactory loss. European Archives of Oto-Rhino-Laryngology. 2017;274(7):2819-25.
23. Gupta S, Lee JJ, Perrin A, Khan A, Smith HJ, Farrell N, et al. Efficacy and safety of saline nasal irrigation plus theophylline for treatment of COVID-19–related olfactory dysfunction: the SCENT2 phase 2 randomized clinical trial. JAMA Otolaryngology–Head & Neck Surgery. 2022;148(9):830-7.
24. Lee JJ, Peterson AM, Kallogjeri D, Jiramongkolchai P, Kukuljan S, Schneider JS, et al. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction. American journal of otolaryngology. 2022;43(2):103299.
25. Esquinas-Requena JL, Lozoya-Moreno S, García-Nogueras I, Atienzar-Núñez P, Sánchez-Jurado PM, Abizanda P. La anemia aumenta el riesgo de mortalidad debido a fragilidad y discapacidad en mayores: Estudio FRADEA. Atencion primaria. 2020;52(7):452-61.